338 related articles for article (PubMed ID: 33417196)
1. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
3. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
Kowada A
Dig Dis Sci; 2023 May; 68(5):1735-1746. PubMed ID: 36565366
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival.
Yeh JM; Ho W; Hur C
Gastrointest Endosc; 2010 Jul; 72(1):33-43. PubMed ID: 20430384
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
Xie F; Luo N; Lee HP
World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.
Kowada A
Epidemiol Infect; 2018 Oct; 146(14):1834-1840. PubMed ID: 30056808
[TBL] [Abstract][Full Text] [Related]
7. Early-Stage Gastric Cancer Can Be Found in Improved Atrophic Mucosa over Time from Successful Helicobacter pylori Eradication.
Majima A; Handa O; Naito Y; Dohi O; Okayama T; Yoshida N; Kamada K; Katada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Yagi N; Itoh Y
Digestion; 2017; 95(3):194-200. PubMed ID: 28288471
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer.
Shin DW; Yun YH; Choi IJ; Koh E; Park SM
Helicobacter; 2009 Dec; 14(6):536-44. PubMed ID: 19889071
[TBL] [Abstract][Full Text] [Related]
9. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
Han Y; Yan T; Ma H; Yao X; Lu C; Li Y; Li L
Dig Dis Sci; 2020 Jun; 65(6):1679-1688. PubMed ID: 31673902
[TBL] [Abstract][Full Text] [Related]
11. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
[TBL] [Abstract][Full Text] [Related]
12. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
13. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.
Feng T; Zheng Z; Xu J; Cao P; Gao S; Yu X
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011621
[TBL] [Abstract][Full Text] [Related]
16. Metachronous gastric cancer after successful Helicobacter pylori eradication.
Shiotani A; Haruma K; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11552-9. PubMed ID: 25206262
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
[TBL] [Abstract][Full Text] [Related]
18. A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity.
Teng AM; Kvizhinadze G; Nair N; McLeod M; Wilson N; Blakely T
BMC Infect Dis; 2017 Feb; 17(1):156. PubMed ID: 28219322
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of different screening strategies for helicobacter pylori infection in Iran: A model-based evaluation.
Yousefi M; Rezaei S; Khoshbaten M; Sarmasti M
Helicobacter; 2023 Dec; 28(6):e13027. PubMed ID: 37839058
[TBL] [Abstract][Full Text] [Related]
20. Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic surveillance.
Sakitani K; Nishizawa T; Arita M; Yoshida S; Kataoka Y; Ohki D; Yamashita H; Isomura Y; Toyoshima A; Watanabe H; Iizuka T; Saito Y; Fujisaki J; Yahagi N; Koike K; Toyoshima O
Helicobacter; 2018 Aug; 23(4):e12503. PubMed ID: 29924436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]